Idenix Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference

Idenix Pharmaceuticals to Present at the Goldman Sachs Global
Healthcare Conference 


CAMBRIDGE, Mass., June 7  /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals,
Inc. (NASDAQ:IDIX) announced today that Jean-Pierre Sommadossi, Ph.D., Idenix's
chairman and chief executive officer, will present a corporate overview at the
upcoming Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference on
Tuesday, June 14, 2005 at 2:00 p.m. PT at the Ritz Carlton Laguna Niguel, Dana
Point, CA.

The live and archived webcast of the Goldman Sachs presentation can be accessed
at http://customer.talkpoint.com/GOLD006/061305a_mk/default.asp?entity=idenix
or under "Events" in the Idenix Investor Center at http://www.idenix.com/.  The
archived replay will be available on the Idenix website for two weeks following
the presentation.

About Idenix:

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the
discovery and development of drugs for the treatment of human viral and other
infectious diseases. Idenix's current focus is on the treatment of infections
caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus
(HIV).  Idenix's headquarters are located in Cambridge, Massachusetts and it
has drug discovery operations in Montpellier, France and Cagliari, Italy.

  Contact:
   Idenix Pharmaceuticals, Inc.
   Media: Teri Dahlman [phone]
   Investors: Amy Sullivan [phone]


DATASOURCE: Idenix Pharmaceuticals, Inc.



CONTACT: Teri Dahlman, Media, [phone], or Amy Sullivan,

Investors, [phone], both of Idenix Pharmaceuticals, Inc.



Web site:  http://www.idenix.com/

Copyright